Published in Medical Letter on the CDC and FDA, July 19th, 2009
"In the past few years, numerous data accumulated oil the immunogenicity and safety of plant-made vaccines against bio-security-related organisms. In addition, expression levels achieved for these antigenic proteins are practical for the production Of Sufficient material for large-scale vaccination programs," wrote M.M. Rigano and colleagues.
The researchers concluded: "These data...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.